| Akela Pharma to cut costs to sustain long-term viability of the ... - Canada NewsWire (press release) |
|
|
Akela's pipeline also includes a growth hormone releasing hormone (GHRH), which is being developed for frailty and wasting in chronic renal disease. ... |